Kimball Electronics has an update. It now appears the Chairman and the CEO will both retire after this spin off is complete. Additionally, they updated the credit line and foreign tax information. This spin off and parent company continue to look unattractive.
New Senior Investment Group gave an update with nothing changing the opinion that this is not an attractive spin off.
CU Bancorp (CUNB) and 1st Enterprise Bank (FENB) will merge for equity pending shareholder voting.
Tyco International (TYC) is moving from Switzerland to Ireland as not only a tax inversion, but also to skirt criminal liabilities, executive compensation rules and shareholder voting laws. They are worried these areas will change pending new regulation that allows citizens to vote laws into being without legislative review.
Susser Holdings Corporation (SUSS) and Energy Transfer Partners (ETP) will merge for cash and equity.
FSP 50 South Tenth Street Corp is planning to sell it’s building and disolve.
Vapor Corp (VPCO) and International Vapor Group will merge as an asset sale.
R. G. Barry Corporation (DFZ) and MRGB Holding Co. will merge for cash.
Family Dollar Stores, Inc (FDO) and Dollar Tree (DLTR) will merge for cash and equity.
LVB Acquisition, Inc., who was created for Zimmer Holdings, Inc. (ZMH), to help merge with Biomet, Inc. for cash, equity and assumption of debt.
Trulia (TRLA) and Zillow (Z) will merge for equity.
Old National Bancorp (ONB) and LSB Financial Corp (LSBI) will merge for cash.
Questcor Pharmaceuticals Inc (QCOR) and Mallinckrodt Pharmaceuticals (MNK) will merge for cash.
CU Bancorp (CUNB) and 1st Enterprise Bank (FENB) will merge for equity.
Triquint Semiconductor Inc. (TQNT) and RF Micro Devices Inc. (RFMD) will merge for equity.
Chiquita Brands (CQB) and Fyffes plc will merge for equity.
Intermountain Community Bancorp (IMCB) and Columbia Banking System Inc. (COLB) will merge for cash and equity.
Tyco (TYC) will merge with itself to move to Ireland.
Coviden (COV) and Medtronic (MDT) will merge for cash in this inversion.
First Citizen’s BankShares (FCNCA) will merge with First Citizen’s Bancorporation as a share swap.
Georgia-Carolina Bancshares (GECR) and State Bank Financial Corporation (STBZ) will merge for a cash and stock transaction.
Lorillard, Inc. (LO) and Reynolds American Inc. (RAI) will merge for cash and equity.
AbbVie continues to pursue Shire Plc (SHPGY) for another inversion.
GFI Group Inc. (GFIG) and CME Group (CME) will merge for cash.
Boulder Growth & Income Fund, I (BIF) and
Journal Communications INC (JRN) and E.W. Scripps (SSP) will merge for equity then plan spin off the newspaper business.
The Williams Company (WMB) acquired 50% of Access Midstream Partners LP (ACMP) for equity and cash.
C&J Energy Services (CJES) and Nabor’s are merging to get the tax advantages of Bermuda using cash and equity.
Rockwood Holdings, Inc. (ROC) and Horizon Oil Ltd. (HZN) will merge for equity.
Home Bancshares (HOMB) and Broward Financial Holdings will merge for for cash and equity.
Fiat and Chrysler will merge.
Going forward only new mergers or merger consideration will be discussed.
Lantheus (LNTH) will trade on the NASDAQ with trade around $15 with a history of negative income and cash flows.
Healthequity (HQY) will trade around $12 on the NASDAQ and has a positive history of income and cash flows.
VTTI Energy (VTTI) will trade on the NYSE for $21 and has a positive history of cash flows and income.
Zosano Pharma (ZSAN) will trade on the NASDAQ for $12 although it has a mixed history of earnings and cash flow.
Westlake Chemical Parnters (WLKP) is the exciting pick this week as it is owned by Westlake Chemical Corp. (WLK) and has a positive history of earning and cash flows. One to watch for sure.
Royal Bank of Canada issued notes.
CONTRAFECT CORP (CFRXU) issued stock and warrants with its history of negative earnings and cash flows.
Loxo Oncology (LOXO) will trade on the NASDAQ for $14 with its history of negative earning and cash flows.
Sirva, Inc. (SRVA) will trade on the NASDAQ for $17 with a history of negative earnings and cash flow, although the most recent operating cash flow was positive.
Marinus Pharmaceuticals, Inc. (MRNS) will trade for $14 on the NASDAQ with a history of negative earning and cash flow.
Auris Medical Holding AG (EARS) will trade on the NASDAQ for $14 with a negative history of earning and cash flows.
Transocean Partners LLC (RIGP) was headed to the NYSE at $21 with a history of positive income and cash flows.
Macrocure Ltd. (MCUR) trades on the NASDAQ at $15 with negative income and cash flows.
Vascular Biogenics Ltd (VBLX) is on the NASDAQ for $15 with negative income and cash flows.
BioPlast Pharma (ORPN) is on the NASDAQ for $13 with negative cash flows and income.
Avalance Biotechnologies, Inc. (AAVL) will trade on NASDAQ for $17 with negative income and cash flows.
FCB Financial Holdings, Inc. (FCB) will on NYSE will be $23 for a history of negative income and cash flows.
Atara Biotherapeutics will trade for $16 on NASDAQ for negative income and cash flows.
Catalent, Inc. (CTLI) will trade for $22 with NYSE with negative income and cash flows.
Tobira Therapeutics, Inc. (TBRA) will trade for $14 with negative earnings.